Since it is already a well-established therapeutic intervention for diabetes, targeting adiponectin might be a new promising therapeutic approach for the prevention of long-term consequences of obesity such as pulmonary remodeling and reduced lung function. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.